Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5192_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Dedications
- •Contributors
- •Acknowledgments
- •Preface
- •1 Basic science
- •1.1 Structure and function of the skin
- •Epidermis
- •Cellular biology of the epidermis
- •Dermal cells of importance
- •Structural components and cell biology of the dermis
- •1.2 Embryology
- •1.3 Wound healing
- •Dermis
- •1.4 Genetics
- •Basic cell biology of genome
- •Inheritance patterns
- •1.5 Ultraviolet light
- •Ultraviolet light (Fig. 1.8)
- •Minimal erythema dose
- •1.6 Immunology
- •Innate immunity
- •Adaptive immunity
- •1.6.2 Immunologic mediators
- •Cytokines
- •Pattern recognition receptors
- •Antimicrobial proteins (AMPs)
- •The complement system
- •B cells
- •T cells (majority of lymphocytes)
- •Innate lymphoid cells
- •NK cells
- •Mononuclear phagocytes
- •Langerhans cells
- •Dendritic cells
- •Mast cells
- •Eosinophils
- •Neutrophils
- •1.6.4 Major histocompatibility complex
- •1.7 Laboratory techniques
- •1.7.1 Tissue acquisition and processing
- •Polymerase chain reaction (PCR)
- •Quantitative reverse transcriptase PCR (qRT-PCR)
- •16S ribosomal RNA (rRNA) sequencing
- •DNA sequencing
- •RNA sequencing
- •Fluorescence in situ hybridization (FISH)
- •Immunohistochemistry (IHC)
- •Enzyme-linked immunosorbent assay (ELISA)
- •1.7.3 Cellular engineering and gene therapy
- •2 Dermatopharmacology
- •2.1 ANTIHISTAMINES
- •Mechanism
- •Other antihistamines
- •Introduction
- •Mucocutaneous
- •Systemic
- •Teratogenicity
- •Contraindications
- •Interactions
- •2.3 CORTICOSTEROIDS
- •Hypothalamic-pituitary-adrenal (HPA) axis suppression (Box 2.1)
- •Psychiatric changes
- •Contraindications
- •Pregnancy
- •Clinical use
- •Intramuscular CS
- •Pulse IV CS
- •Adalimumab
- •Certolizumab pegol
- •Golimumab
- •Indications
- •Ustekinumab
- •IL-17 inhibitors
- •IL-23 inhibitors
- •Spesolimab
- •Rituximab
- •IL-1 inhibitors
- •Omalizumab
- •Dupilumab
- •Lebrikizumab and tralokinumab
- •Nemolizumab
- •Vismodegib and sonidegib
- •Intralesional CS
- •Monitoring
- •2.4 IMMUNOMODULATORY AGENTS
- •Apremilast and other PDE-4 inhibitors
- •Janus Kinase (JAK) and Tyro inhibitors
- •Agents used in dermatology
- •Laboratory monitoring
- •Azathioprine
- •Important monitoring points
- •Cyclosporine
- •Important pharmacology points
- •Indications
- •Important monitoring points
- •Methotrexate
- •Important pharmacology points
- •Indications and contraindications
- •Important monitoring points
- •Important pharmacology points
- •Indications
- •Monitoring guidelines
- •Cytotoxic agents
- •Hydroxyurea
- •Cyclophosphamide
- •Chlorambucil
- •Antimalarial agents
- •Important pharmacology points
- •Indications
- •Dapsone
- •Important pharmacology points
- •Indications
- •Important monitoring points
- •Etanercept
- •MEK inhibitors (trametinib, cobimetinib, binimetinib)
- •Ipilimumab
- •PD-1 inhibitors (pembrolizumab, nivolumab, cemiplimab) and PD-L1 inhibitors (avelumab, atezolizumab)
- •Imatinib mesylate
- •Ibrutinib
- •Talimogene
- •Mechlorethamine hydrochloride
- •Brentuximab vedotin
- •Mogamulizumab
- •Romidepsin and vorinostat
- •2.6 ANTIMICROBIAL AGENTS
- •Topical antibacterial agents
- •Bacitracin
- •Benzoyl peroxide
- •Metronidazole
- •Azelaic acid
- •Systemic antibacterial agents
- •Penicillins
- •Polymyxin B
- •Neomycin
- •Mupirocin
- •Retapamulin
- •Gentamicin
- •Iodoquinol
- •Cephalosporins
- •Vancomycin
- •Macrolides
- •Fluoroquinolones
- •Tetracyclines
- •Clindamycin
- •Carbapenems
- •Linezolid
- •Daptomycin
- •Others
- •Antiviral agents
- •Acyclovir
- •Valacyclovir
- •Famciclovir and penciclovir
- •Foscarnet
- •Bleomycin
- •Podophyllin resin and podophyllotoxin
- •Cantharidin
- •Sinecatechins
- •5-Fluorouracil and imiquimod (discussed in section 2.5)
- •I. Azoles
- •Itraconazole
- •Fluconazole
- •Ketoconazole
- •Voriconazole
- •Posaconazole
- •Miconazole, clotrimazole, and econazole
- •Efnaconazole
- •Luliconazole
- •II. Allylamines/benzylamines
- •Terbinafne
- •Butenafne
- •IV. Ciclopirox olamine
- •VI. Nystatin
- •VIII. Tavaborole
- •Antiparasitic agents (Tables 2.7 and 2.8)
- •2.7 PHOTOTHERAPY
- •UVA modalities
- •Psoralen plus UVA (PUVA)
- •UVA-1 (340–400 nm)
- •UVB modalities
- •Extracorporeal photochemotherapy
- •Photodynamic therapy (PDT)
- •2.8 MISCELLANEOUS AGENTS
- •Sunscreens
- •Topical cosmetic agents
- •Bimatoprost
- •Brimonidine and oxymetazoline
- •Hydroquinone
- •Psychiatric agents
- •Antiandrogens and androgen inhibitors
- •Spironolactone
- •Finasteride and dutasteride
- •Combination oral contraceptive pills
- •Clascoterone
- •Calcipotriene and calcitriol
- •Attenuated androgens
- •Danazol and stanozolol
- •Colchicine
- •Potassium iodide
- •Thalidomide
- •Topical calcineurin inhibitors
- •Pimecrolimus and tacrolimus
- •Intravenous immunoglobulin (IVIG)
- •Glycopyrrolate
- •Oxybutynin
- •Botulinum toxin
- •Aluminum chloride
- •2.9 DRUG INTERACTIONS AND THE CYTOCHROME P-450 SYSTEM
- •Key points
- •CYP1A2
- •CYP2C9
- •CYP2D6
- •CYP3A4 (most relevant to dermatologists)
- •Classic CYP mnemonics
- •2.10 DRUG REACTIONS
- •Urticaria, angioedema, and anaphylaxis
- •Fixed drug eruption/Stevens-Johnson syndrome/toxic epidermal necrolysis
- •Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS)
- •Acute generalized exanthematous pustulosis (AGEP)
- •Photosensitive drug reactions
- •Drug-induced pigmentary changes
- •Bullous drug reactions, lichenoid drug eruptions, drug-induced connective tissue disease
- •Other drug eruptions
- •3 General dermatology
- •3.1 Papulosquamous dermatoses
- •3.2 Eczematous dermatoses
- •3.3 Interface dermatitis
- •Vacuolar interface dermatitis
- •Autoimmune connective tissue disease (AICTD)
- •Erythema multiforme (EM)
- •Stevens-johnson syndrome (SJS), and toxic epidermal necrolysis (TEN, lyell’s syndrome)
- •Pityriasis lichenoides
- •Fixed drug eruption (FDE)
- •Graft- versus- host disease (GVHD)
- •Lichenoid interface dermatitis
- •Lichen planus (LP)
- •Keratosis lichenoides chronica (KLC)
- •Erythema dyschromicum perstans (ashy dermatosis)
- •Lichenoid keratosis (benign lichenoid keratosis [BLK], LP-like keratosis)
- •Lichen nitidus
- •3.4 Blistering diseases
- •Pemphigus disease family
- •Pemphigus vulgaris (PV)
- •Pemphigus foliaceus (PF)
- •Paraneoplastic pemphigus (PNP)/paraneoplastic autoimmune multiorgan syndrome (PAMS)
- •Autoimmune subepidermal blistering diseases
- •Bullous pemphigoid (BP; pemphigoid)
- •Mucous membrane pemphigoid (MMP; cicatricial pemphigoid)
- •Linear IgA bullous dermatosis/chronic bullous disease of childhood (LABD/CBDC)
- •Epidermolysis bullosa acquisita
- •Bullous systemic lupus erythematosus
- •Dermatitis herpetiformis (duhring disease)
- •Inherited blistering diseases
- •Epidermolysis bullosa (see chapter 4)
- •Darier disease (keratosis follicularis)
- •Other blistering diseases
- •Lupus band test (LBT)
- •Lupus erythematosus
- •Chronic cutaneous lupus erythematosus (CCLE)
- •Subacute cutaneous lupus erythematosus
- •Acute cutaneous lupus erythematosus (ACLE)
- •Other rare cutaneous lupus variants
- •Systemic lupus erythematosus (SLE)
- •Drug-induced SLE (DI-SLE)
- •Lupus-related diseases
- •Other autoimmune connective tissue diseases and sclerosing dermopathies
- •Dermatomyositis (DM)
- •Sjögren’s syndrome
- •Relapsing polychondritis
- •Mixed connective tissue disease (MCTD)
- •Rheumatoid arthritis
- •Systemic-onset juvenile idiopathic arthritis (still’s disease)
- •Morphea (localized scleroderma)
- •Eosinophilic fasciitis (shulman syndrome)
- •Abnormalities of connective tissue
- •3.6 Granulomatous/histiocytic disorders
- •Non-infectious granulomas
- •Granuloma annulare (GA)
- •Annular elastolytic giant cell granuloma (actinic granuloma of O’Brien
- •Interstitial granulomatous dermatitis and arthritis (IGDA) and palisaded neutrophilic granulomatous dermatitis (PNGD)
- •Interstitial granulomatous drug eruption
- •Necrobiosis lipoidica (necrobiosis lipoidica diabeticorum, NLD)
- •Necrobiotic xanthogranuloma (NXG)
- •Cutaneous crohn’s disease
- •Sarcoidosis
- •Histiocytoses
- •Langerhans cell histiocytosis (LCH)
- •Non-langerhans cell histiocytoses (discussed in Table 3.23)
- •Malignant histiocytic disorders
- •3.7 Monoclonal gammopathies of dermatologic interest
- •3.8 Xanthomas
- •3.9 Urticaria and angioedema
- •3.10 Neutrophilic dermatoses
- •Amicrobial pustulosis of the folds
- •3.11 Eosinophilic disorders
- •Granuloma faciale
- •Eosinophilic folliculitis
- •Papuloerythroderma of ofuji
- •Wells’ syndrome (eosinophilic cellulitis)
- •Hypereosinophilic syndrome (HES)
- •3.12 Figurate erythemas
- •3.13 Follicular and eccrine/apocrine disorders
- •Acne variants
- •Acne fulminans
- •Acne conglobata
- •Solid facial edema in acne
- •Acne mechanica
- •Neonatal acne (neonatal cephalic pustulosis)
- •Infantile acne
- •Transverse nasal crease
- •Acne in setting of endocrinologic abnormality
- •Acne cosmetica
- •Pomade acne
- •Chloracne
- •Radiation acne
- •Acneiform eruptions
- •Drug-induced acne
- •Acne-associated syndromes
- •SAPHO (chronic recurrent multifocal osteomyelitis)
- •PAPA
- •HAIR-AN
- •Apert syndrome (acrocephalosyndactyly)
- •Rosacea
- •Epidemiology
- •Rosacea subtypes
- •Erythematotelangiectatic (vascular)
- •Phymatous
- •Ocular
- •Rosacea variants
- •Solid facial edema in rosacea (morbihan disease and rosacea lymphedema)
- •Pyoderma faciale (rosacea fulminans)
- •Granulomatous rosacea
- •Lupus miliaris disseminatus faciei
- •Folliculitis
- •Gram-negative folliculitis
- •Hot tub folliculitis
- •Eosinophilic folliculitis
- •Disseminate and recurrent infundibulofolliculitis
- •Viral-associated trichodysplasia
- •Pseudofolliculitis barbae
- •Acne keloidalis nuchae
- •Follicular occlusion tetrad (acne conglobata, hidradenitis suppurativa, dissecting cellulitis of the scalp, and pilonidal cyst)
- •Hidradenitis suppurativa (acne inversa)
- •Pilonidal cyst
- •Dissecting cellulitis of the scalp and acne conglobata (discussed in alopecia and acne sections)
- •Other diseases of eccrine and apocrine sweat glands
- •Hyperhidrosis
- •Hypohidrosis and anhidrosis
- •Miliaria
- •Bromhidrosis
- •Chromhidrosis
- •Fox-fordyce disease (apocrine miliaria)
- •3.14 Drug reactions
- •3.15 Photodermatoses and other physical dermatoses
- •Temperature-related dermatoses
- •Thermal burns
- •Erythema ab igne
- •Cold injuries
- •Photoaging
- •Polymorphous light eruption
- •Hydroa vacciniforme (see Chapter 4)
- •Actinic folliculitis
- •Chronic actinic dermatitis
- •Actinic prurigo (see chapter 4)
- •Solar urticaria
- •Mechanical injuries
- •3.17 Neurodermatology and psychodermatology
- •Cutaneous manifestations of psychiatric illness or self-induction
- •Delusions of parasitosis
- •Excoriation disorder (neurotic excoriations)
- •Factitial dermatitis/dermatitis artefacta
- •Gardner-diamond syndrome
- •Body dysmorphic disorder
- •Cupping/coining
- •Other neurocutaneous dermatoses
- •Scalp dysesthesia/burning scalp syndrome
- •Burning mouth syndrome
- •Brachioradial pruritus
- •Notalgia paresthetica
- •Meralgia paresthetica
- •Trigeminal trophic syndrome
- •Familial dysautonomia/riley-day syndrome
- •Auriculotemporal nerve syndrome (frey syndrome)
- •3.18 Palmoplantar keratodermas
- •3.19 Nutritional disorders in dermatology
- •3.21 Ulcers (Table 3.33)
- •3.22 Vasculitides, vasculopathies, and other vascular disorders
- •Subtypes of cutaneous small vessel vasculitis
- •Henoch-schonlein purpura (HSP)
- •Epidemiology
- •Pathophysiology
- •Clinical presentation
- •Key features of adult HSP
- •Key features of childhood HSP
- •Treatment
- •Laboratory testing: See CSVV section
- •Pathology
- •Acute hemorrhagic edema of infancy (Fig 3.86)
- •Epidemiology
- •Pathophysiology
- •Clinical presentation
- •Treatment
- •Urticarial vasculitis
- •Epidemiology
- •Pathophysiology
- •Clinical presentation
- •Pathology
- •Laboratory testing
- •Treatment (Table 3.41)
- •Erythema elevatum diutinum
- •Epidemiology
- •Pathophysiology
- •Clinical presentation
- •Pathology
- •Treatment
- •Mixed cryoglobulinemia (see cryoglobulinemia section)
- •Small to medium vessel vasculitis
- •Granulomatosis with polyangiitis (wegener)
- •Epidemiology
- •Pathophysiology
- •Clinical presentation
- •Pathology
- •Treatment
- •Microscopic polyangiitis (MPA)
- •Epidemiology
- •Pathophysiology
- •Clinical presentation
- •Pathology
- •Laboratory testing: See CSVV, especially:
- •Treatment
- •Eosinophilic granulomatosis with polyangiitis (churg-strauss syndrome)
- •Epidemiology
- •Pathophysiology
- •Clinical presentation: Three classic stages (Table 3.47)
- •Pathology
- •Laboratory testing
- •Treatment
- •Medium vessel vasculitis
- •Subtypes: PAN and kawasaki’s disease
- •Polyarteritis nodosa
- •Epidemiology
- •Pathophysiology
- •Clinical presentation
- •Pathology
- •Laboratory testing: See CSVV
- •Treatment
- •Kawasaki disease (acute febrile mucocutaneous lymph node syndrome)
- •Epidemiology
- •Pathophysiology
- •Clinical presentation (Fig. 3.90)
- •Laboratory testing
- •Treatment
- •Key testing facts
- •Large vessel vasculitis
- •Subtypes: Temporal arteritis and Takayasu’s arteritis
- •Temporal arteritis (giant cell arteritis)
- •Epidemiology
- •Pathophysiology
- •Clinical presentation
- •Pathology
- •Laboratory workup
- •Treatment
- •Takayasu’s arteritis
- •Epidemiology
- •Pathophysiology
- •Clinical presentation
- •Pathology
- •Laboratory workup
- •Treatment
- •Summary of organ system involvement in various vasculitides (Table 3.49)
- •Cryoglobulinemias
- •Epidemiology
- •Thrombosis and thrombotic syndromes
- •Important subtypes
- •Calciphylaxis
- •Antiphospholipid syndrome
- •Epidemiology
- •Pathophysiology
- •Clinical presentation
- •Pathology
- •Treatment
- •Pathogenesis
- •Clinical presentation
- •Pathology
- •Treatment
- •Other vasculopathies (Table 3.51)
- •Other vascular disorders
- •Venous lake
- •Telangiectasia
- •Erythromelalgia
- •Livedo reticularis (LR)
- •Angiospastic macules (bier spots)
- •3.23 Panniculitides and lipodystrophies
- •3.24 Dermatoses of pregnancy
- •3.25 Hair, nail, and mucosal disorders
- •Non-scarring alopecia
- •Androgenetic alopecia
- •Trichotillomania
- •Alopecia areata
- •Temporal triangular alopecia
- •Congenital atrichia with papules
- •Cicatricial (scarring) alopecia
- •Central centrifugal cicatricial alopecia
- •Lichen planopilaris
- •Acne keloidalis nuchae
- •Dissecting cellulitis of the scalp (perifolliculitis capitis abscedens et suffodiens)
- •Folliculitis decalvans
- •Traction alopecia
- •Hair shaft abnormalities
- •Hypertrichosis and hirsutism
- •Hypertrichosis
- •Nail disorders
- •Mucosal disorders
- •3.26 Pigmentary disorders
- •Disorders of hypopigmentation and depigmentation
- •Vitiligo
- •Halo nevus
- •Chemical and physical agent-induced hypopigmentation
- •Idiopathic guttate hypomelanosis
- •Progressive macular hypomelanosis
- •Nevus anemicus
- •Pigmentary mosaicism
- •Hypomelanosis of ito
- •Nevus depigmentosus
- •Disorders of hyperpigmentation
- •Melasma
- •Erythema dyschromicum perstans (ashy dermatosis) discussed in Section 3.3
- •Lichen planus pigmentosus
- •Linear and whorled nevoid hypermelanosis
- •Prurigo pigmentosa
- •Familial progressive hyperpigmentation
- •Endocrinopathies
- •Pigmentary demarcation lines (aka futcher’s lines, voight lines, ito’s lines)
- •4 Pediatric dermatology
- •4.1 Neonatal dermatology
- •4.2 Viral exanthems and select infectious disorders of childhood
- •4.3 Inherited pigmentary disorders
- •Hypo-/depigmentation
- •Pigmentary mosaicism
- •Oculocutaneous albinism (OCA)
- •Silvery hair syndromes
- •Griscelli syndrome
- •Hermansky-Pudlak syndrome
- •Piebaldism
- •Waardenburg syndrome
- •Hyperpigmentation
- •McCune-Albright syndrome
- •Lentiginoses syndromes
- •Hereditary dyschromatoses
- •Dyschromatosis symmetrica hereditaria (acropigmentation of Dohi)
- •Dyschromatosis universalis hereditaria
- •Naegeli-Franceschetti-Jadassohn syndrome (NFJS)/dermatopathia pigmentosa reticularis (DPR)
- •4.4 Epidermolysis bullosa
- •4.5 Tumor syndromes
- •4.6 Vascular tumors, malformations, and related vascular disorders
- •Vascular tumors
- •Phace syndrome
- •LUMBAR/SACRAL syndrome
- •Multiple hemangiomas
- •Kasabach-Merritt phenomenon
- •Vascular malformations
- •Capillary malformations (CM)
- •Sturge-Weber syndrome (encephalotrigeminal angiomatosis)
- •Phakomatosis pigmentovascularis
- •Phakomatosis pigmentokeratotica
- •PIK3CA-related overgrowth spectrum (PROS)
- •Klippel-trenaunay syndrome
- •Macrocephaly capillary malformation syndrome
- •Cloves syndrome
- •Proteus syndrome
- •Beckwith-wiedemann syndrome
- •Diffuse capillary malformation with overgrowth (DCMO)
- •Venous malformations
- •Maffucci syndrome (enchondromas with multiple angiomas)
- •Blue rubber bleb nevus syndrome
- •Glomulovenous malformations (GVMs; previously termed “glomangiomas”)
- •Lymphatic malformations
- •Macrocystic lymphatic malformations (cystic hygroma)
- •Gorham-stout (disappearing bone) disease
- •Congenital lymphedema (hereditary congenital lymphedema, Nonne-Milroy syndrome)
- •Arteriovenous malformations
- •AVMs
- •Parkes-weber syndrome
- •Cobb syndrome (cutaneomeningospinal angiomatosis)
- •Other vascular disorders
- •4.7 Disorders of hair and nails
- •Pachyonychia congenita
- •Ectodermal dysplasias
- •Hypohidrotic ectodermal dysplasia (Christ-Siemens-Touraine syndrome)
- •Hidrotic ectodermal dysplasia (Clouston syndrome)
- •Ectodermal dysplasias due to p63 mutation
- •Schöpf-Schulz-Passarge syndrome
- •Other disorders
- •Rubinstein-Taybi syndrome
- •Parakeratosis pustulosa
- •Congenital malalignment of the great toenails
- •4.8 Inherited metabolic and nutritional disorders
- •4.9 Inherited connective tissue disorders
- •4.10 Autoinflammatory disorders (periodic fever syndromes)
- •4.12 Premature aging syndromes and DNA repair disorders
- •4.13 Primary immunodeficiency disorders with cutaneous manifestations
- •4.14 Disorders of cornification
- •Actinic prurigo
- •Diaper dermatitis
- •Juvenile plantar dermatosis
- •Acropustulosis of infancy
- •Trichorhinophalangeal syndrome
- •Midas syndrome (also MLS or microphthalmia with linear skin defects)
- •H syndrome
- •Cutaneous mastocytosis
- •Neutrophilic eccrine hidradenitis of childhood
- •5 Infectious diseases
- •5.1 Viral diseases
- •Herpes simplex virus (HHV-1/HSV-1 and HHV-2/HSV-2)
- •Varicella zoster virus (VZV; HHV-3)
- •Epstein-Barr virus (HHV-4)
- •Cytomegalovirus (HHV-5)
- •HHV-6 (Roseola infantum, exanthem subitum, sixth disease)
- •HHV-7
- •HHV-8
- •Poxviruses
- •Zika virus
- •Dengue virus
- •Viral hepatitides (Table 5.2)
- •Viral-associated trichodysplasia of immunosuppression
- •COVID-19
- •5.2 HIV/AIDS dermatology
- •5.3 Bacterial infections
- •Staphylococcal skin infections
- •Corynebacterial skin infections
- •Clostridium skin infections
- •Filamentous bacteria
- •Other gram-positive infections
- •Pseudomonas
- •Bartonella
- •Rickettsia
- •Other gram-negative skin infections
- •Borrelia
- •Nonvenereal (endemic) treponematoses
- •Syphilis
- •Cutaneous tuberculosis
- •Leprosy (hansen’s disease)
- •Atypical mycobacteria
- •Tinea versicolor (pityriasis versicolor)
- •Piedra
- •Tinea nigra
- •Sporotrichosis
- •Lobomycosis
- •Mycetoma (madura foot)
- •Chromoblastomycosis
- •Histoplasmosis
- •Blastomycosis (“north American blastomycosis”)
- •Coccidioidomycosis
- •Paracoccidioidomycosis (“South American blastomycosis”)
- •Candidiasis
- •Cryptococcosis
- •Aspergillosis
- •Fusarium
- •Penicilliosis
- •Zygomycosis (mucormycosis)
- •Phaeohyphomycosis
- •Protothecosis
- •Rhinosporidiosis
- •5.5 Parasites and other creatures
- •Parasitic infestations
- •Scabies
- •Lice
- •Tungiasis
- •Myiasis
- •Protozoa
- •Leishmaniasis
- •Toxoplasmosis
- •Helminths
- •Cutaneous larva migrans
- •Larva currens
- •Onchocerciasis (“river blindness”)
- •Loiasis
- •Filariasis
- •Swimmer’s itch and seabather’s eruption
- •Trichinosis
- •Dracunculiasis (guinea worm)
- •Gnathosomiasis
- •Cysticercosis
- •Cutaneous amebiasis
- •Free-living amoeba
- •Gi-associated amoeba
- •Bites and stings
- •Biting and stinging insects
- •Arachnids (ticks, mites, spiders, and scorpions)
- •Millipedes and centipedes
- •Snake bites
- •6 Neoplastic dermatology
- •Neoplastic dermatology
- •6.1 Keratinocytic neoplasms
- •Premalignant/malignant
- •Actinic keratosis (AK)
- •Bowen’s disease (squamous cell carcinoma in situ)
- •Invasive cutaneous squamous cell carcinoma (cSCC, “SCC”)
- •Verrucous carcinoma
- •Keratoacanthoma
- •Basal cell carcinoma
- •6.2 Cysts
- •6.3 Melanocytic neoplasms
- •6.4 Adnexal neoplasms and hamartomas
- •Comparative dermatopathologic features of sweat gland neoplasms for board exam purposes
- •Poroma (classic juxtaepidermal type)
- •Hidroacanthoma simplex
- •Dermal duct tumor
- •Hidradenoma
- •Spiradenoma
- •Cylindroma
- •Syringoma
- •Mixed tumor (MT; “chondroid syringoma”)
- •Hidradenoma papilliferum (HPAP)
- •Syringocystadenoma papilliferum (SPAP, SCAP)
- •Papillary eccrine adenoma (PEA)
- •Tubular apocrine adenoma (TAA)
- •Porokeratotic eccrine ostial and dermal duct nevus
- •Microcystic adnexal carcinoma (MAC)
- •Aggressive digital papillary adenocarcinoma (ADPA)
- •Adenoid cystic carcinoma (ACC)
- •6.5 Hair follicle neoplasms/hamartomas
- •Folliculo-sebaceous-apocrine hamartomas
- •Trichofolliculoma
- •Fibrofolliculoma
- •Nevus sebaceus
- •Neoplasms with follicular germinative differentiation
- •Trichoepithelioma
- •Neoplasms with follicular matrix differentiation
- •Pilomatricoma (calcifying epithelioma of malherbe)
- •Neoplasms with follicular sheath (trichilemmal) differentiation
- •Trichilemmoma
- •Desmoplastic trichilemmoma (DTL)
- •Tumor of the follicular infundibulum (TFI)
- •Trichoadenoma (TA; of Nikolowski)
- •Proliferating pilar (trichilemmal) tumor
- •6.6 Sebaceous proliferations
- •6.7 Neural neoplasms
- •6.8 Smooth muscle neoplasms
- •6.9 Hematolymphoid neoplasms
- •6.10 Fibrohistiocytic neoplasms
- •Multinucleate cell angiohistiocytoma
- •Nodular fasciitis
- •Fibrous hamartoma of infancy
- •Giant cell tumor of tendon sheath (tenosynovial giant cell tumor)
- •Connective tissue nevus (collagenoma and elastoma)
- •6.11 Vascular proliferations
- •Benign vascular lesions
- •Vascular malformation (includes “port wine stain,” “cavernous hemangioma” old terminology)
- •Intravascular papillary endothelial hyperplasia (masson tumor, pseudoangiosarcoma)
- •Angiokeratoma
- •Infantile hemangioma
- •Pyogenic granuloma (lobular capillary hemangioma)
- •Epithelioid hemangioma (angiolymphoid hyperplasia with eosinophils, ALHE)
- •Targetoid hemosiderotic lymphatic malformation (hobnail hemangioma, targetoid hemosiderotic hemangioma)
- •Tufted angioma
- •Glomeruloid hemangioma
- •Glomus tumor/glomangioma
- •Borderline vascular neoplasms
- •Kaposiform hemangioendothelioma
- •Kaposi sarcoma (KS)
- •Other borderline vascular neoplasms (rare; not commonly tested)
- •High-grade malignant vascular neoplasms
- •Angiosarcoma
- •Vascular neoplasm associations
- •6.12 Neoplasms of adipocytic lineage
- •6.13 Dermoscopy
- •Seborrheic keratosis
- •Actinic keratosis
- •Basal cell carcinoma
- •Squamous cell carcinoma in situ
- •Squamous cell carcinoma
- •Ink spot lentigo
- •Vascular lesions (e.g., cherry angiomas)
- •Hemorrhage
- •Porokeratosis
- •Sebaceous hyperplasia
- •Dermoscopic patterns of melanocytic lesions
- •7 Dermatopathology
- •7.1 Essential concepts in dermatopathology
- •7.2 High-yield dermatopathology diagnoses at a glance
- •7.3 High-yield dermatopathology differential diagnoses
- •8 Dermatologic surgery
- •8.1 Surgical anatomy
- •8.2 Local anesthetics and perioperative pain control
- •8.3 Surgical instruments and needles
- •8.4 Suture techniques
- •8.5 Wound closure materials
- •8.7 Electrosurgery
- •8.8 Cryosurgery
- •8.9 Excisions
- •8.10 Mohs surgery
- •8.11 Flaps
- •8.12 Grafts
- •8.13 Surgical complications and measures to avoid them
- •8.14 Scar improvement
- •8.15 Nail surgery
- •8.16 Wound dressings
- •9 Cosmetic dermatology
- •9.1 Lasers

7.3 High-Yield Dermatopathology Differential Diagnoses
Table 7.20 Blue Balls in Dermis
Cylindroma Multiple basaloid tumor micronodules fused together in jigsaw pattern, small ducts, and thick hyaline (pink) BMZ material
Spiradenoma Larger basophilic dermal nodules with sweat ducts, hyaline droplets within tumor micronodules, and lymphocytes “peppered
Dermal duct tumor Nodule of monomorphous poroid cells w/ cuticle-lined sweat ducts. No epidermal connection
Glomus tumor Monomorphous glomus cells encircling delicate blood vessels ; lacks sweat ducts (vs. dermal duct tumor)
Hidradenoma
Trichoblastoma Dermal/SQ basaloid nodules (solid or cribriform), fibroblast-rich pink collagenous stroma, papillary mesenchymal bodies , and
Table 7.21 Clonal SK vs. Hidroacanthoma Simplex vs. Bowen’s Disease
Clonal SK
Hidroacanthoma
simplex
Bowen’s disease Full thickness keratinocyte atypia (“windblown” appearance) with atypical mitoses, dyskeratotic keratinocytes (not seen in other
Table 7.22 Pagetoid DDx
Disease Essential Features Immunostaining Profile
Pagetoid Bowen’s disease Clear cytoplasm, intercellular bridges, and involves basal layer
EMPD/Paget’s disease Mucin in cytoplasm; nests of Paget cells compress the healthy basal layer
Melanoma in situ Pigmented, expect to see some nesting at base of rete
Mycosis fungoides Lymphocytes lining up at DEJ; irregular nuclear contours (“cerebriform”),
Peri-ocular sebaceous
carcinoma
surrounding each tumor micronodule
into tumor”
Nodule comprised of a mixture of squamoid and clear cells with sweat ducts; keloidal/hyalinized stroma; 1/– cystic
degeneration (“solid-cystic hidradenoma”)
horn cysts; lacks stromal mucin and retraction (vs. BCC), lacks ducts (vs. sweat gland neoplasms)
Intraepidermal nests of keratinocytes w/ minimal atypia; cell size $ surrounding keratinocytes; lacks ducts
Acanthotic epidermis w/ intraepidermal nests of small poroid cells (smaller than surrounding keratinocytes); small ducts present at
least focally
two entities)
CK5/61, CK7-(usually), BerEP4–
of keratinocytes; 1/– ducts (Fig. 7.45)
perinuclear halo around lymphocytes (“lumps of coal resting on a
pillow”), and “wiry” papillary dermal fibrosis (abnormally thickened
collagen fibers in papillary dermis entrapping lymphocytes) ( Fig. 7.46)
Eyelid skin (pagetoid spread is rare in extra-ocular sebaceous carcinoma),
pale vacuolated cytoplasm with indented/scalloped central nuclei
Cytokeratin 71, CK20–, CEA1, BerEP41 (helps
to distinguish from pagetoid Bowen’s, which is
negative)
1
, Melan-A1, HMB-45
S100
CD31, CD41, CD8 (Exception 5
hypopigmented MF, which is usually CD81 and
CD4–). Often see loss of CD5 and CD7 (most
common aberrant staining pattern)
Adipophilin1, AR1, EMA1, BER-EP4-
1
Fig. 7.45 Extramammary Paget disease. Pagetoid cells with ample cytoplasm,
sometimes containing vacuoles 1/– mucin. Basal keratinocytes are often compressed/crushed by tumor nests (helps to DDx from melanoma, where the tumor
nests do not compress the basal layer of epidermis).
Fig. 7.46 Mycosis fungoides.
425

CHAPTER 7 • Dermatopathology
Table 7.23 Square Biopsy DDx
Disease
Chronic radiation
dermatitis
Necrobiosis
lipoidica
Normal skin of the
back
Scar Yes (fibroblasts) “East-West” collagen
SclerEdema No
SclerOderma/
Morphea
Sclerodermoid
GVHD
Scleromyxedema/
NSF
Increased
Cellularity? Essential Features
No Homogenized (“sick-appearing”)
Yes
(granulomatous)
No Normal thickness of collagen
No (exception:
early/inflammatory
morphea has
perivascular
lymphoplasmacytic
inflammation)
No Thick collagen bundles,
Yes (fibroblasts)
dermis, prominent superficial
telangiectasias, stellate
fibroblasts, and loss of
adnexae (Fig. 7.47)
Diffuse granulomatous
inflammation w/ “cake-
layered” necrobiosis,
dermal sclerosis (late-stage),
multinucleated GCs, and
↑ plasma cells
bundles—they just extend
deeper!.
orientation with ↑
broblast cellularity, vertically
oriented blood vessels
Hypertrophic scars have
“whorled” broblastic nodules
↑ Space and ↑ mucin
between normal-sized
collagen fibers (Fig. 7.48)
Thick hyalinized (pink)
collagen bundles, loss of
perieccrine fat, and deep PV
inflammatory infiltrate with
plasma cells (Fig. 7.49)
mild vacuolar interface,
pigment incontinence,
and loss of adnexae
↑ Fibroblasts in dermis (NSF
extends deeper into SQ), mild
collagen thickening,
and ↑ mucin (see Fig. 7.24)
Fig. 7.48 Scleredema. (From Ferringer T: Metabolic disorders. In: Elston DM,
Ferringer T, eds. Dermatopathology, 3rd ed. Philadelphia: Elsevier; 2019; pp 251-263.)
Fig. 7.47 Chronic radiation dermatitis. Dermal sclerosis, with ectatic supercial
vessels and bizarre broblasts.
426
A
B
Fig. 7.49 Morphea. Sclerosis of collagen bers centered in the deep reticular
dermis, with trapping/ablation of adnexal structures, and lymphoplasmacytic
inammation in a perivascular pattern (often present at dermo-pannicular
junction)

7.3 High-Yield Dermatopathology Differential Diagnoses
Table 7.24 “SLAM” DDx: Malignant Dermal Spindle Cell Tumor “Slammed” Up Against the Epidermis
Disease Essential Features Immunostaining Profile
SCC (spindle cell type)
Leiomyosarcoma Hyperchromatic spindle cells w/ fascicular
AFX Bizarre/atypical mitotic figures; mixture of cell
Melanoma, (desmoplastic/
spindle cell type)
Overlying epidermal keratinocytic atypia 1/
epidermal connection
architecture and cigar-shaped nuclei w/
perinuclear vacuoles (glycogen)
types (multinucleated GCs, histiocyte-like cells,
foam cells, and spindle cells)
Atypical junctional melanocytic proliferation (often subtle),
solar elastosis, blue-gray myxoid stroma, and
nodular lymphocyte aggregates, PNI (Fig. 7.50)
Cytokeratin1 (CK5/6, CK903 and MNF116 are most sensitive),
p631, p401 (most specific marker for SCC vs. AFX)
SMA1, Desmin1
AFX is a diagnosis of exclusion!
Most importantly, must be negative for: Cytokeratin, p63, p40,
S100, SOX-10, and Desmin (caution: SMA may have “tram
track”/myobroblast-like staining in AFX)
Most useful positive stains: CD101 (also positive in many spin-
dle cell SCCs), Procollagen-1 1
Other positive stains: CD681, CD741 (weak in AFX, strong in
UPS), CD991 and CD1171 (latter two stains are non-specic)
S1001, SOX-101 (differentiates from scar), and p75/NGFR1 (useful
desmoplastic melanomas)
for S100
A B
Fig. 7.50 Malignant melanoma with a junctional and desmoplastic component. Dermal lymphoid aggregates may be a clue to the presence of a desmoplastic
component.
Table 7.25 Psoriasiform and Spongiotic Disorders
Plaque psoriasis Regular (“psoriasiform”) acanthosis, neutrophil microabscesses in stratum corneum (Munro) and spinosum (Kugoj),
Guttate psoriasis
Pustular psoriasis Sub- and intracorneal neutrophilic abscesses
Lichen simplex chronicus Irregular acanthosis, hypergranulosis, and vertical collagen in dermal papillae; lacks neutrophilic microabscesses
Mycosis fungoides Hyperchromatic, cerebriform epidermotropic lymphocytes w/ perinuclear halo (“lumps of coal on a pillow”); minimal
PRP Hyperkeratosis out of proportion to degree of acanthosis, “checkerboard” parakeratosis (parakeratosis horizontally and
Secondary syphilis Psoriasiform hyperplasia (long, “sexy & slender” rete); supercial and deep inammation; “dirty” lichenoid inammation
Subacute spongiotic
dermatitis
hypogranulosis, confluent parakeratosis, suprapapillary plate thinning, dilated vessels in dermal papillae, and little or no
serum crust
Minimal acanthosis, 1spongiosis, mounds of neutrophils w/ underlying parakeratosis (thicker and more adherent than
pityriasis rosea) (Fig. 7.51)
spongiosis relative to number of lymphocytes in epidermis, band-like superficial dermal lymphocytic infiltrate with minimal
to no inflammation deep to superficial vessels (“bare underbelly sign”), lymphocytes “tagging” basal layer of epidermis
(“pigs lining up at the trough”), wiry papillary dermal fibrosis, and absence of intraepidermal neutrophils (see Fig. 7.26)
vertically alternating with orthohyperkeratosis), follicular plugging , “shoulder parakeratosis” (around follicular ostia), focal
acantholysis (helpful clue), and thickened suprapapillary plates ; NO NEUTS! (Fig. 7.52)
w/ neutrophils and plasma cells, lymphocyte exocytosis, and swollen endothelial cells
CAUTION: has neutrophils in horn!
Mild to moderate acanthosis 1/– parakeratosis, prominent spongiosis, Langerhans cell “microabscesses” in spinous
layer (esp. allergic contact dermatitis)
CAUTION: neutrophils may be seen but are limited to areas of serum crust; lacks intraspinous neutrophil microabscesses
Continued
427

CHAPTER 7 • Dermatopathology
Table 7.25 Psoriasiform and Spongiotic Disorders—cont'd
Pityriasis rosea Subacute spongiotic dermatitis w/ thin mounds of parakeratosis (lacks neutrophils seen in psoriasis), and extravasated
ILVEN Horizontally alternating orthokeratosis (WITH granular layer) and parakeratosis (WITHOUT granular layer). Low-power view is
Tinea
Nutritional deficiency
dermatitis
RBCs around superficial dermal vessels (Fig. 7.53)
helpful.
Epidermal changes may resemble psoriasis or spongiotic dermatitis → clue: “layered” stratum corneum (compact stratum
corneum immediately above granular layer), “bullet holes” (hyphae) in compact keratin, and sub/intracorneal neutrophil
abscesses
Psoriasiform hyperplasia with confluent parakeratosis AND pallor of upper 1/3 of epidermis (Fig. 7.54)
Fig. 7.51 Guttate psoriasis. Adherent mounds of parakeratosis with overlying
neutrophilic microabscesses. Only focal hypogranulosis 1/– mild spongiosis.
Acanthosis is far more subtle than that in classic psoriasis.
Fig. 7.53 Pityriasis rosea. RBC, red blood cell. (From Elston DM: Psoriasiform
and spongiotic dermatitis. In: Elston DM, Ferringer T, eds. Dermatopathology,
3rd ed. Philadelphia: Elsevier, 2019; pp 153-164.)
Fig. 7.52 Pityriasis rubra pilaris. Hyperkeratosis out of proportion to degree of
acanthosis. Alternating “checkerboard” parakeratosis.
428
Fig. 7.54 Nutritional deciency. (From Ferringer T: Metabolic disorders. In: Elston DM,
Ferringer T, eds. Dermatopathology, 2nd ed. Philadelphia: Elsevier, 2014;
pp 224-233.)

7.3 High-Yield Dermatopathology Differential Diagnoses
Box 7.1 Mnemonic
“Neuts in the horn (stratum corneum) = PTICSS”
Psoriasis, Tinea, Impetigo, Candida, Seborrheic dermatitis, Syphilis
From Elston DM, Ferringer T, eds. Dermatopathology, 3rd ed. Philadelphia:
Elsevier; 2019, p 505.
Table 7.26 Acantholytic Disorders
Disease H&E DIF Notes
Pemphigus
foliaceus
Pemphigus
vulgaris
Pemphigus
vegetans
Pemphigus
erythematosus
Paraneoplastic
pemphigus
Hailey-Hailey Epidermal hyperplasia, full-thickness
Darier’s disease Acantholytic dyskeratosis (prominent) with
Grover’s disease May appear in a pemphigus-like, Darier-like, or
Warty
dyskeratoma
Subcorneal split, acantholysis in granular layer like
“shingles blowing off of a roof”
Suprabasilar split, “tombstoning of basal layer,”
and acantholysis extends down hair follicles
PEH with eosinophilic abscesses in epidermis;
subtle suprabasilar clefting
Similar to pemphigus foliaceus
Combination of suprabasilar acantholysis and
interface dermatitis
intraepidermal acantholysis (“dilapidated brick
wall”), mild dyskeratosis, and keratinocytes have
distinct pink-red cytoplasm (Fig. 7.55)
suprabasilar clefting (Fig. 7.56)
Hailey-Hailey-like pattern
Endophytic with either cup shape
hair follicle; prominent acantholytic dyskeratosis
with cells expelled into the center of the crater
leaving dermal papillae looking like “villi”
or resembling
Intercellular IgG and C3 Due to anti-Dsg1 antibodies
Same as pemphigus foliaceus,
Pemphigus pattern (intercellular
BMZ (linear to granular) 1
DIF:classically shows combo
IIF: positive on rat bladder
Negative Less dyskeratosis compared with Darier’s
Negative Dyskeratosis manifests as corps ronds/grains
Negative May have mix of all three patterns. If a mix of patterns
Negative Solitary nature and cup-shaped architecture are
Box 7.2 Mnemonic
“Subcorneal pustules = CAT PISS”
Candida, Acropustulosis of infancy, Transient neonatal pustular melanosis,
Pustular psoriasis, Impetigo, Sneddon-Wilkinson (and IgA pemphigus),
Staph scalded skin
Modied from Elston DM, Ferringer T, eds. Dermatopathology, 3rd ed.
Philadelphia: Elsevier; 2019, p 505.
Most important Ddx is staph scalded skin → DIF
distinguishes
but w/ ↑ staining in lower half
of epidermis
IgG and C3)
intercellular pemphigus
pattern
of intercellular pemphigus
pattern 1 lichenoid changes;
appears similar to
pemphigus erythematosus
epithelium (because rat
bladder contains plakins)
Due to anti-Dsg1 and anti-Dsg3 antibodies
Clinical variant of PV
Overlap of pemphigus foliaceus and cutaneous
lupus erythematosus
Anti-desmoglein 1 and ANA 1
Antiplakin family antibodies (including BP-230)
detected with immunoblotting or ELISA
May be associated with B-cell lymphoproliferative
disorders (most common), thymoma,
Castleman’s disease, some carcinomas,
sarcomas, and even melanoma
Associated with life-threatening bronchiolitis
obliterans (#2 cause of death; #1 is underlying
malignancy progression)
seen on path, favor Grover’s, but CPC required
the most helpful clues to distinguish from Darier’s.
Acantholytic acanthoma is not cup-shaped
Fig. 7.55 Hailey-Hailey disease. In contrast to Darier disease, dyskeratosis is
usually minimal or even absent.
Fig. 7.56 Darier disease. Acantholytic dyskeratosis is seen.
429

CHAPTER 7 • Dermatopathology
Table 7.27 High-Yield Granulomatous Disorders (Fig. 7.57)
GA (interstitial)
GA (palisaded) Palisaded histiocytes in superficial-mid dermis (except deep GA) encircling and degrading collagen fibers;
Gout Palisaded granuloma around light pink/gray feathery needle-shaped crystals (best seen if fixed in ethanol) (Fig. 7.59)
Lupus miliaris disseminatus faciei Large foci of caseation necrosis (amorphic pink debris) surrounded by histiocytes on facial skin
Necrobiosis lipoidica
NXG X-shaped red zones of necrosis w/ nuclear debris within granulomas; cholesterol clefts and bizarre, HUGE
Rheumatoid nodule Deep dermal-SQ palisaded granuloma surrounding pink fibrin; no mucin (Fig. 7.62)
Sarcoid Well-formed epithelioid granulomas w/ minimal surrounding lymphocytic inflammation (“ naked”); often difficult to
Patchy interstitial histiocytes, ↑ mucin, lymphocytes, and ↑ eosinophils
↑ mucin; PV infiltrate with ↑ eosinophils (Fig 7.58a and 7.58b)
Layered pan-dermal granulomatous inflammation and necrobiosis ( “layered lasagna”), pan-dermal process n
entire dermis appears altered, with “square biopsy” sign, and plasma cells; lacks eosinophils (vs. GA) (Fig. 7.60)
multinucleate giant cells (often with 50–100 nuclei in horseshoe or osteoclast-like pattern)( Fig. 7.61)
distinguish from Crohn’s disease, Melkersson-Rosenthal syndrome, zirconium/beryllium deposition, Blau syndrome,
perioral dermatitis, and tuberculoid leprosy. Foreign material may be present (“scar-coid”) and does not exclude
diagnosis (Fig. 7.63)
NONINFECTIOUS GRANULOMAS: ALGORITHM FOR HISTOLOGIC DIAGNOSIS
Non-infectious granulomas
With plasma
“Naked”
Sarcoidosis
Epithelioid
tubercle
Caseation
Crohn’s
disease
Appreciable
lymphocytes
Consider
infection
Syphilis
cells
With
lymphocytes
Granulomatous
slack skin
Diffuse infiltrate,
no palisade
With
neutrophils
Ruptured cyst
or follicle
Palisaded
granuloma
Horizontal
“tiers”
Prominent
Necrobiosis
lipoidica
Necrobiotic
xanthogranuloma
Granuloma
annulare*
Elastophagocytosis
Superficial
dermal
Nodular
infiltrate
Diffuse infiltrate,
marked collagen
alteration
Subcutis
cholesterol
clefts
Annular elastolytic
giant cell granuloma
Fig. 7.57 Non-infectious granulomas: algorithm for histopathologic diagnosis. Interstitial granulomatous dermatitis and palisaded neutrophilic and granulomatous
dermatitis may represent an additional diagnostic consideration. May also have a patchy dermal interstitial pattern without palisades, or subcutaneous palisades, with
more mucin than rheumatoid nodules. (From Rosenbach MA, Wanat KA, Reisenauer A, White KP, Korcheva V, White CR Jr. Non-infectious granulomas. In: Bolognia JL,
Schaffer JV, Cerroni L, eds. Dermatology. 4th ed. Philadelphia: Elsevier; 2018:1644–1663.)
Rheumatoid
nodule
430

7.3 High-Yield Dermatopathology Differential Diagnoses
A B
Fig. 7.58 Granuloma annulare (palisaded variant) with palisading granulomatous inammation, central necrobiosis of collage, and increased mucin. Palisaded appearance is best observed at low power.
Fig. 7.59 Gout. Granulomatous inammation surrounding light pink, needleshaped crystals.
A
B
Fig. 7.60 Necrobiosis lipoidica. (A) Low magnication reveals layered pan-dermal
granulomatous inammation with necrobiosis; “wall-to-wall” process with no
remaining normal dermis. (B) High magnication.
431

CHAPTER 7 • Dermatopathology
A
Fig. 7.62 Rheumatoid nodule. Deep and large palisaded granuloma with central
pink brin; lacks mucin (vs GA)
B
Fig. 7.61 Necrobiotic xanthogranuloma. Low power (A) showing pan-dermal
granulomatous inammation. High power (B) demonstrates cholesterol clefts
and bizarre, large multinucleated histiocytic giant cells. (From Johnston RB.
Granulomatous reaction pattern. In: Weedon’s Skin Pathology Essentials, 2nd
ed. Philadelphia: Elsevier, 2017, pp 134-162.)
Fig. 7.63 Sacroidosis. “Naked, well-formed granulomas” comprised of discrete
balls of granulomatous inammatory cells (histiocytes and giant cells) with
minimal-to-no surrounding lymphocytes.
432

7.3 High-Yield Dermatopathology Differential Diagnoses
Table 7.28 Histopathologic Features of the Major Granulomatous Dermatitides (See also Fig. 7.57)
Palisading
Neutrophilic and
Granulomatous
Dermatitis
Entire dermis
Palisading;
prominent
neutrophils and
leukocytoclasia
Variable
Sarcoidosis
Typical location Superficial and
deep dermis
Granuloma pattern Tubercle with
few peripheral
lymphocytes
(“naked”)
Granuloma
Annulare
Superficial and
a
mid dermis
Palisading or
interstitial
Necrobiosis
Lipoidica AEGCG
Entire dermis,
a
subcutis
Diffuse
palisading
and interstitial;
horizontal
Superficial
and mid
dermis
Palisading,
irregular
Cutaneous
Crohn’s
Disease
Superficial and
deep dermis
Tubercle with
surrounding
lymphocytes
Rheumatoid
Nodule
Deep
dermis,
subcutis
Palisading Palisading in
Interstitial
Granulomatous
Dermatitis
Mid and deep
dermis
small “rosettes”
“tiers”
Necrobiosis (altered
No Yes (“blue”) Yes (“red”) No No Yes (“red”) Yes (“blue”) Yes (“blue”)
collagen)
Giant cells Yes Variable Yes Yes Yes Yes Variable Variable
Elastolysis No Variable Variable Yes No No Variable Variable
Elastophagocytosis No No No Yes No No No No
Asteroid bodies Yes Variable Variable Yes No No Variable Variable
Mucin No Yes Minimal No No Variable Yes (but less than
palisaded GA)l
Extracellular lipid No Variable Yes No No Variable No No
Vascular changes No Variable Yes
a
Subcutaneous variant can also occur.
No No Yes No Yes
AEGCG, Annular elastolytic giant cell granuloma.
Modied from Rosenbach MA, Wanat KA, Reisenauer A, White KP, Korcheva V, White CR Jr. Non-infectious granulomas. In: Bolognia JL, Schaffer JV, Cerroni L,
eds. Dermatology. 4th ed. Philadelphia: Elsevier; 2018: 1644–1663.
Table 7.29 High-Yield Inammatory and Occlusive Vascular Disorders
Vasculitides (Vessel Inammation and Destruction, Fibrin in Vessel Wall, RBC Extravasation, and Leukocytoclasis)
Henoch-Schönlein purpura LCV, IgA in vessel walls (DIF)
Mixed cryoglobulinemia LCV
Granulomatosis with polyangiitis
(Wegener’s)
Eosinophilic granulomatosis with
polyangiitis (Churg-Strauss)
LCV involving vessels high up (postcapillary venules) and down low (medium-sized vessels) → may evolve into palisading
granuloma with giant cells surrounding neutrophil-rich abscess, 1/– granulomatous vasculitis
LCV involving vessels up high (postcapillary venules) and down low (medium-sized vessels) → may evolve into palisading
granuloma with central degranulating eosinophils and flame figures, 1/– granulomatous vasculitis (Fig. 7.64)
Erythema elevatum diutinum LCV with numerous eosinophils, “ onion-skin” fibrosis, and nonfacial location (Fig. 7.65)
Granuloma faciale
LCV w/ numerous eosinophils, plasma cells and histiocytes, Grenz zone, mild fibrosis (,EED), and most commonly on face (Fig. 7.66)
Occlusive vasculopathies (“Plugged” Vessels w/ Minimal Primary Vascular Inammation)
Thrombotic Intravascular thrombus
Causes: cryoglobulinemia type I (intravascular deposits are PAS positive; uorescence with multiple conjugates on DIF),
warfarin necrosis, DIC, lupus anticoagulant, Factor V Leiden mutation, and protein C or S deciency → all are essentially
indistinguishable histopathologically
Livedoid vasculopathy Bright pink-red hyalinized vessel walls (“red crayon-like”), intravascular thrombosis of superficial dermal vessels, and
background stasis changes
Calciphylaxis
Levamisole-associated
vasculopathy
Calcified vessel walls w/ thrombosis deep in the fat, 1/– extravascular calcium debris (esp. peri-eccrine)
Mixed features of LCV 1 small vessel thrombosis high in dermis
Patients also have neutropenia and P- and/or C-ANCA antibodies
Fig. 7.64 Flame gure, seen in eosinophilic cellulitis (Wells syndrome), Churg-Strauss, and other brisk
allergic or dermal hypersensitivity reactions (bug bite, drug, etc). Due to eosinophil degranulation onto
collagen bers.
433

CHAPTER 7 • Dermatopathology
A
Fig. 7.65 Erythema elevatum diutinum, (A) Low power, (B) High power: Characterized by multiple dermal nodules comprised of nodules of storiform (“onion skin”) brosis
around destroyed vessels, and subtle features of LCV with conspicuous eosinophils. Differentiated from g. faciale by high degree of onion skin brosis and non-facial
location. (B, from Elston DM: Inammatory vascular diseases. In: Elston DM, Ferringer T, eds. Dermatopathology, 3rd ed. Philadelphia: Elsevier, 2019; pp 193-219.)
B
A B
Fig. 7.66 Granuloma faciale. (A) Low power, (B) High power: Characterized by Grenz zone, dense dermal perivascular LCV with numerous eosinophils, plasma cells
and histiocytes. Much less onion-skin brosis compared to EED.
Table 7.30 High-Yield Panniculitides
Cold panniculitis (deep perniosis)
Erythema induratum/nodular
vasculitis
Erythema nodosum
Lupus panniculitis
Sclerema neonatorum Lobular panniculitis w/ radiating needle-shaped crystals within adipocytes; lacks surrounding granulomatous inflammation
SQ fat necrosis of newborn
(and poststeroid panniculitis)
PAN Vasculitis of solitary medium-sized vessel (artery) in deep dermis/SQ tissue with fibrin in vessel wall and obliteration of
Pancreatic panniculitis Lobular panniculitis w/ amorphous purple aggregates in fat lobules representing enzymatic fat necrosis (“ghost cells”) (Fig. 7.68)
Lipodermatosclerosis (stasis
panniculitis)
Lobular fat necrosis with lymphocytes, histiocytes, and neuts at dermal-pannicular junction; 1/– overlying dermal perniosis
Caseous necrosis of fat lobules (neutrophil-rich) 1 vasculitis of small and medium (PAN-sized) lobular and septal
vessels 1 septal thickening
Major clue: involves lobules and septae diffusely, whereas PAN involves one lobule and only damages a small amount of fat
immediately surrounding the affected vessel
Septal panniculitis with neutrophils in septum (early) → progresses to septal thickening w/ small granulomas with
central clefting (Miescher’s granulomas)
Note: there is only slight spill-over of inammation into the lobules
Lobular fat necrosis w/ pink hyalinization around fat, nodular PV/PA lymphoplasmacytic aggregates, 1/ clusters
CD1231 plasmacytoid dendritic cells in vast majority of cases (very helpful to DDx from SPTCL, which lacks CD123+
cells) 1/– ↑ mucin and interface dermatitis
Lobular panniculitis w/ radiating needle-shaped crystals within adipocytes w/ associated brisk granulomatous
inflammation
lumen, 1/ very mild lobular panniculitis in area immediately adjacent to affected vessel ( Fig. 7.67)
Lobular panniculitis w/ cystic fat necrosis and with lipomembranous change (“frost on a window pane”), septal
fibrosis, lipophages, and overlying stasis changes
434
Соседние файлы в папке Библиотека им академика М.И. Перельмана
